Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease
The Long Run with Luke Timmerman
00:00
Federation Bio's clinical results and wind down
Emily describes manufacturing a 100-strain consortia, a trial for oxalate degradation, and underwhelming clinical results.
Play episode from 31:26
Transcript
